939 related articles for article (PubMed ID: 15144546)
21. The management of hypogonadism in aging male patients.
Sharma V; Perros P
Postgrad Med; 2009 Jan; 121(1):113-21. PubMed ID: 19179819
[TBL] [Abstract][Full Text] [Related]
22. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
23. Testosterone replacement for hypogonadism: clinical findings and best practices.
Hengge UR
AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
[TBL] [Abstract][Full Text] [Related]
24. Declining testicular function in aging men.
Tenover JS
Int J Impot Res; 2003 Aug; 15 Suppl 4():S3-8. PubMed ID: 12934044
[TBL] [Abstract][Full Text] [Related]
25. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
26. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
[TBL] [Abstract][Full Text] [Related]
27. Testosterone therapy: treatment of metabolic disturbances in heart failure.
Naghi JJ; Philip KJ; DiLibero D; Willix R; Schwarz ER
J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):14-23. PubMed ID: 21097668
[TBL] [Abstract][Full Text] [Related]
28. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
29. Testosterone replacement therapy for the primary care physician.
Casey RW; Barkin J
Can J Urol; 2008 Aug; 15 Suppl 1():71-7; discussion 77. PubMed ID: 18700068
[TBL] [Abstract][Full Text] [Related]
30. Testosterone and men's quality of life.
Moncada I
Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
32. Clinical hypogonadism and androgen replacement therapy: an overview.
Ohl DA; Quallich SA
Urol Nurs; 2006 Aug; 26(4):253-9, 269; quiz 260. PubMed ID: 16939042
[TBL] [Abstract][Full Text] [Related]
33. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
Kaufman J
Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
[TBL] [Abstract][Full Text] [Related]
34. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A; Black AM; Emerson LE
BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
[TBL] [Abstract][Full Text] [Related]
35. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
Mäkinen JI; Huhtaniemi I
Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
[TBL] [Abstract][Full Text] [Related]
36. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
Raynor MC; Carson CC; Pearson MD; Nix JW
Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
[TBL] [Abstract][Full Text] [Related]
37. Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
Heaton JP
Can J Urol; 2002 Dec; 9(6):1677-80. PubMed ID: 12517308
[TBL] [Abstract][Full Text] [Related]
38. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
Harman SM
Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
[TBL] [Abstract][Full Text] [Related]
39. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype.
Carrero JJ; Stenvinkel P
Nephrol Dial Transplant; 2012 Nov; 27(11):4030-41. PubMed ID: 22962412
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
